Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
01 1Curia India Private Limited
02 1EUROAPI Germany GmbH
03 2Assia Chemical Industries Ltd - Teva Tech Site
04 1DARMERICA, LLC
05 2F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
06 1Haleos Labs Limited
07 2Ipca Laboratories Limited
08 1KALCHEM INTERNATIONAL INC
09 1KALINTIS HEALTHCARE PRIVATE LIMITED
10 1LETCO MEDICAL, LLC
11 1Medisca
12 1Olon S.p.A.
13 1Professional Compounding Centers of America
14 1Professional Compounding Centers of America dba PCCA
15 1Spectrum Laboratory Products, Inc.
16 1Sri Krishna Pharmaceuticals Ltd. Unit I
01 8FUROSEMIDE
02 10Furosemide
03 1Furosemide Micro
01 1France
02 4India
03 2Israel
04 3Italy
05 5U.S.A
06 2United Kingdom
07 2Blank
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
NDC Package Code : 70193-0002
Start Marketing Date : 1983-11-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
NDC Package Code : 82348-105
Start Marketing Date : 1995-12-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0053
Start Marketing Date : 2010-03-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0054
Start Marketing Date : 2010-03-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-0006
Start Marketing Date : 2012-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3306
Start Marketing Date : 2024-03-05
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0087
Start Marketing Date : 2019-03-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0078
Start Marketing Date : 2019-11-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0342
Start Marketing Date : 2024-07-02
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-3222
Start Marketing Date : 1997-08-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
56
PharmaCompass offers a list of Furosemide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Furosemide manufacturer or Furosemide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Furosemide manufacturer or Furosemide supplier.
A Farsix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Farsix, including repackagers and relabelers. The FDA regulates Farsix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Farsix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Farsix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Farsix supplier is an individual or a company that provides Farsix active pharmaceutical ingredient (API) or Farsix finished formulations upon request. The Farsix suppliers may include Farsix API manufacturers, exporters, distributors and traders.
click here to find a list of Farsix suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Farsix as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Farsix API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Farsix as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Farsix and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Farsix NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Farsix suppliers with NDC on PharmaCompass.
We have 13 companies offering Farsix
Get in contact with the supplier of your choice:
